Skip to content

Clinical trials

Hypoparathyroidism trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20162
20171
20181
20191
20202
20212
20221
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Calcilytix Therapeutics, Inc., a BridgeBio company2
Hospices Civils de Lyon2
Shire2
Aix Marseille Université1
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Assistance Publique - Hôpitaux de Paris1
Central Hospital, Nancy, France1
Centre Hospitalier Universitaire de Nīmes1
European Georges Pompidou Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism15
Hypocalcemia5
Hypercalciuria3
Calcium Metabolism Disorders2
Metabolic Diseases2
Muscular Diseases2
Musculoskeletal Abnormalities2
Musculoskeletal Diseases2
Nephrocalcinosis2
Nephrolithiasis2

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.